HemaSphere

Stay at the forefront of cutting-edge research with EHA’s open access, peer-reviewed journal.  

Ranked #7 of indexed hematology journals worldwide, and with a confirmed 2023 Impact Factor of 11.9, HemaSphere is an invaluable resource for hematologists at every career stage. 

Our continuous online publications support the global hematology community by sharing: 

  • Results of high-impact basic, translational, and clinical hematology research 
  • Insightful review articles  
  • Clinical practice guidelines 
  • Reports of new therapies 
  • Recommendations for future research and clinical applications 
  • Discussions on European policy 
  • And more 

We also provide the hematology community with a friction-free route to publishing and publication access through our: 

  • Fast and constructive review process 
  • 100% open access content 
  • Low publication fees 

Latest issue

Explore this month’s HemaSphere issue, featuring a broad range of hematology papers and insightful discussions on trending topics. 

HemaSphere podcast

Listen to the latest HemaSphere podcast and enjoy lighthearted conversations about the research stories behind the publications.  

This audio companion to our official journal is available on a range of podcast platforms, and we launch new episodes regularly. 

Call for novel findings

HemaSphere is interested in high-impact studies that share novel findings.  

If your study fits this description, please feel free to submit it online for our consideration. HemaSphere does not charge any submission fees. 

Discounted publishing fees for EHA members

Active EHA members can benefit from discounted publishing fees in HemaSphere. Interested in publishing at this discounted rate? Learn more about joining EHA.  

Submit your paper

We welcome your submission. On average, it takes us just 10 days to make a first decision. If you have a manuscript that you think would be a good fit for our journal, please submit your paper. HemaSphere receives all manuscript submissions online. 

Remember, active EHA members benefit from discounted publishing fees.  

HemaSphere Editorial Board

HemaSphere’s Editorial Board is responsible for: 

  • Reviewing and selecting manuscripts for publication 
  • Guiding our journal’s quality, strategy, and growth  

You can find out more about the remit and composition of this body on the HemaSphere Editorial Board page. 

Journal metrics

As a premier hematology information resource, HemaSphere has: 

  • A 2023 Journal Impact Factor (JIF) of 11.9 (source: Journal Citation Reports, Clarivate) 
  • A Scopus 2023 CiteScore of 6.1 

It is also: 

  • Fully indexed in PubMed Central (PMC) 
  • Indexed in Science Citation Expanded Index (SCIE)—Hematology and Clinical Medicine (Clarivate Analytics) 
  • Listed in the Directory of Open Access Journals (DOAJ) 

Our publishing partner

HemaSphere is published by the global research and education specialist, Wiley. Their range of digital and physical platforms enables us to bring HemaSphere to the widest possible audience.  

 

Share